TTK Healthcare
- P/E
- 17.72
Key Fundamentals
MicrocapDiversifiedPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 8.04%
- Debt to Equity
- 0.02
- EPS (TTM)
- ₹52.34
- Book Value
- ₹949.82
- Market Cap
- —
- P/E (TTM)
- 17.72
- P/B
- 0.98
- ROE
- 6.30%
- Dividend Yield
- 1.09%
- EBITDA
- ₹98.30 Cr
- 52W High
- ₹1,247.00
- 52W Low
- ₹735.00
- Day Range
- ₹911.05 – ₹935.00
- Volume
- 11,437
Peer Comparison
Diversified › Diversified Group › Diversified
| ₹28,835.00 | 56.23 | ₹32,776 Cr | 18.38 | 1.75% | 30.00% | 50.00% | ₹5,317 Cr | ₹577 Cr | |
| ₹978.50 | 28.04 | ₹32,717 Cr | 2.95 | 0.00% | 9.26% | 8.17% | ₹23,225 Cr | ₹2,210 Cr | |
| ₹903.55 | 9.84 | ₹14,020 Cr | 1.67 | 0.45% | 11.50% | 11.50% | ₹13,840 Cr | ₹1,436 Cr | |
| ₹163.65 | 10.03 | ₹2,778 Cr | 1.31 | 5.20% | 13.70% | 14.60% | ₹2,785 Cr | ₹274 Cr | |
| TTK Healthcare (this company) | ₹927.50 | 17.72 | ₹1,297 Cr | 0.98 | 1.09% | 6.30% | 8.04% | ₹888 Cr | ₹74 Cr |
| ₹69.97 | 13.13 | ₹204 Cr | 0.96 | 0.72% | 7.48% | 12.00% | ₹1,091 Cr | ₹16 Cr | |
| Median 6 companies | ₹915.53 | 15.43 | ₹8,399 Cr | 1.49 | 0.91% | 10.38% | 11.75% | ₹4,051 Cr | ₹426 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 48
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 52
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 38
- Weak
- Sales & profit trajectory 9% weight
- Financial Health
- 91
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 38
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 57
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 20.4%
Weaknesses
3- Company has a low return on equity of 6.54% over last 3 years.
- Earnings include an other income of Rs.66.9 Cr.
- Working capital days have increased from 86.1 days to 161 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 39.11
- Neutral
- MACD (12,26,9)
- −29.67
- Bearish
- SMA (50)
- 1,045.78
- Bearish
- SMA (200)
- 961.29
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +5.14% |
|---|---|
| 5Y | +12.48% |
| 3Y | +5.73% |
| 1Y | +6.99% |
| TTM | +8.55% |
Net profit
| 10Y | +11.12% |
|---|---|
| 5Y | +7.49% |
| 3Y | −53.11% |
| 1Y | −19.51% |
| TTM | +17.46% |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Turned negative |
| 3Y | Outflow narrowed by ₹4 Cr |
| 1Y | Outflow widened by ₹17 Cr |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −4.68 pp |
|---|---|
| 5Y | −0.96 pp |
| 3Y | −1.25 pp |
| 1Y | −1.34 pp |
| TTM | +0.48 pp |
Revenue by year
| Mar 2017 | ₹528 Cr |
|---|---|
| Mar 2018 | ₹578 Cr |
| Mar 2019 | ₹628 Cr |
| Mar 2020 | ₹646 Cr |
| Mar 2021 | ₹476 Cr |
| Mar 2022 | ₹599 Cr |
| Mar 2023 | ₹725 Cr |
| Mar 2024 | ₹753 Cr |
| Mar 2025 | ₹801 Cr |
| Mar 2026 | ₹857 Cr |
Net profit by year
| Mar 2017 | ₹19.00 Cr |
|---|---|
| Mar 2018 | ₹18.00 Cr |
| Mar 2019 | ₹24.00 Cr |
| Mar 2020 | ₹12.00 Cr |
| Mar 2021 | ₹46.00 Cr |
| Mar 2022 | ₹42.00 Cr |
| Mar 2023 | ₹640 Cr |
| Mar 2024 | ₹63.00 Cr |
| Mar 2025 | ₹82.00 Cr |
| Mar 2026 | ₹66.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 186 | 184 | 181 | 208 | 198 | 205 | 190 | 226 | 204 | 209 | 218 | 258 | 233 |
| Expenses | 192 | 176 | 179 | 169 | 201 | 190 | 197 | 178 | 224 | 198 | 202 | 207 | 243 | 230 |
| Operating Profit | 10 | 10 | 5 | 12 | 7 | 8 | 8 | 12 | 3 | 5 | 7 | 11 | 15 | 4 |
| OPM % | 5% | 5% | 2.9% | 7% | 3.3% | 4.2% | 3.8% | 6% | 1.2% | 2.6% | 3.4% | 5% | 6% | 1.6% |
| Other Income | 15 | 16 | 16 | 16 | 37 | 18 | 18 | 13 | 18 | 19 | 10 | 21 | 17 | 267 |
| Interest | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| PBT | 21 | 22 | 18 | 24 | 41 | 23 | 23 | 22 | 18 | 21 | 14 | 30 | 29 | 268 |
| Tax % | 24% | 26% | 27% | 25% | 23% | 26% | 26% | 26% | 26% | 4% | 25% | 26% | 26% | 17% |
| Net Profit | 16 | 16 | 13 | 18 | 32 | 17 | 17 | 16 | 13 | 20 | 11 | 22 | 21 | 223 |
| EPS (₹) | 11.09 | 11.33 | 9.12 | 12.93 | 22.35 | 12.17 | 11.84 | 11.43 | 9.2 | 14.43 | 7.45 | 15.4 | 15.06 | — |
Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 483 | 519 | 528 | 578 | 628 | 646 | 476 | 599 | 725 | 753 | 801 | 857 | 888 |
| Expenses | 453 | 478 | 489 | 535 | 578 | 617 | 457 | 577 | 694 | 715 | 767 | 831 | 850 |
| Operating Profit | 30 | 40 | 38 | 43 | 50 | 28 | 19 | 22 | 31 | 37 | 35 | 26 | 38 |
| OPM % | 6% | 8% | 7% | 7% | 8% | 4.4% | 4.1% | 3.6% | 4.3% | 5% | 4.3% | 3% | 4.3% |
| Other Income | 7 | 6 | 6 | 8 | 8 | 9 | 28 | 42 | 643 | 63 | 85 | 68 | 67 |
| Interest | 4 | 3 | 3 | 5 | 3 | 3 | 2 | 3 | 5 | 3 | 3 | 3 | 3 |
| Depreciation | 6 | 7 | 12 | 15 | 15 | 14 | 13 | 13 | 13 | 13 | 8 | 9 | 9 |
| PBT | 26 | 36 | 29 | 30 | 39 | 19 | 32 | 48 | 657 | 84 | 108 | 83 | 94 |
| Tax % | 39% | 36% | 36% | 40% | 38% | 37% | −44% | 13% | 3% | 25% | 25% | 20% | — |
| Net Profit | 16 | 23 | 19 | 18 | 24 | 12 | 46 | 42 | 640 | 63 | 82 | 66 | 74 |
| EPS (₹) | 20.81 | 29.19 | 24.13 | 12.86 | 17.25 | 8.72 | 32.87 | 29.43 | 453 | 44.47 | 57.79 | 46.48 | 52.34 |
| Div. Payout % | 22% | 17% | 21% | 39% | 29% | 34% | 18% | 34% | 2% | 22% | 17% | 22% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 110 | 128 | 150 | 219 | 237 | 235 | 281 | 316 | 939 | 987 | 1,051 | 1,101 |
| Borrowings | 42 | 38 | 23 | 47 | 29 | 30 | 19 | 22 | 27 | 23 | 24 | 24 |
| Other Liabilities | 115 | 128 | 104 | 127 | 136 | 152 | 180 | 207 | 189 | 183 | 192 | 190 |
| Total Liabilities | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
| Fixed Assets | 52 | 106 | 99 | 110 | 98 | 89 | 85 | 80 | 71 | 75 | 81 | 73 |
| CWIP | 46 | 1 | 0 | 1 | 2 | 9 | 0 | 0 | 3 | 1 | 0 | 1 |
| Investments | 0 | 10 | 9 | 9 | 13 | 9 | 13 | 15 | 13 | 13 | 11 | 9 |
| Other Assets | 177 | 185 | 177 | 288 | 304 | 325 | 395 | 463 | 1,083 | 1,118 | 1,189 | 1,246 |
| Total Assets | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 39 | 37 | 18 | 25 | 17 | 20 | 96 | 45 | −25 | −5 | −4 | −21 |
| Investing | −49 | −27 | 5 | −22 | 10 | −13 | −77 | −30 | 32 | 28 | 20 | 52 |
| Financing | 3 | −11 | −23 | −7 | −31 | −10 | −17 | −10 | −12 | −22 | −18 | −18 |
| Net Cash Flow | −7 | 0 | 0 | −4 | −4 | −4 | 2 | 5 | −6 | 2 | −2 | 13 |
| Free Cash Flow | −10 | 21 | 12 | 21 | 13 | 8 | 95 | 42 | −36 | −15 | 6 | −25 |
| CFO/OP | 176 | 122 | 67 | 84 | 62 | 108 | 391 | 248 | −28 | 54 | 68 | −31 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 33 | 24 | 35 | 47 | 43 | 46 | 33 | 46 | 42 | 41 | 47 |
| Inventory Days | 62 | 66 | 65 | 80 | 77 | 101 | 123 | 102 | 89 | 105 | 107 | 98 |
| Days Payable | 50 | 53 | 100 | 130 | 101 | 121 | 170 | 134 | 116 | 110 | 106 | 83 |
| Cash Conversion Cycle | 46 | 46 | −11 | −16 | 22 | 23 | −2 | 1 | 19 | 36 | 43 | 63 |
| Working Capital Days | −31 | −38 | −24 | −30 | −6 | −3 | −32 | −28 | 4 | 49 | 48 | 161 |
| ROCE % | 20% | 23% | 18% | 15% | 15% | 8% | 6% | 8% | 10% | 9% | 9% | 8% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view TTK Healthcare insights
63 extracted metrics across FY09–FY27.
Documents
- Concall · Sep 2016PPT
- 30 May 2026
- 23 May 2025
- 22 Sep 2026
- 29 Sep 2025
- 4 Sep 2023
- 7 Jul 2022
- 30 Mar 2022
- General announcements 12 Oct 2026
Frequently Asked Questions about TTK Healthcare
What does TTK Healthcare Ltd do?
Where is TTK Healthcare Ltd (TTKHLTCARE) listed?
Which sector does TTK Healthcare Ltd belong to?
What is the PE ratio of TTK Healthcare Ltd?
What is the 52-week high and low of TTK Healthcare Ltd?
Does TTK Healthcare Ltd pay dividends?
What is the Return on Equity (ROE) of TTK Healthcare Ltd?
Company Information
TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. Human Pharma was divested in May 2022; agreements to sell EVA and Good Home were signed in July 2026.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TTKHLTCARE.md for TTK Healthcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.